These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 22350187

  • 1. Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.
    Ott U, Sauerbrei A, Lange J, Schäfler A, Walther M, Wolf G, Wutzler P, Zell R, Krumbholz A.
    Med Microbiol Immunol; 2012 Aug; 201(3):297-302. PubMed ID: 22350187
    [Abstract] [Full Text] [Related]

  • 2. Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
    Loebermann M, Voss U, Meyer S, Bosse D, Fritzsche C, Klammt S, Frimmel S, Riebold D, Reisinger EC.
    PLoS One; 2013 Aug; 8(8):e70866. PubMed ID: 23976960
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.
    Ottóffy G, Horváth P, Muth L, Sólyom A, Garami M, Kovács G, Nyári T, Molnár D, Pauler G, Jankovics I.
    Pediatr Blood Cancer; 2014 Jun; 61(6):1013-6. PubMed ID: 24395342
    [Abstract] [Full Text] [Related]

  • 4. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ, Müller M, Kollaritsch H, Pinl F, Schmitt B, Zeitlinger M, Loew-Baselli A, Kreil TR, Kistner O, Portsmouth D, Fritsch S, Maritsch F, Aichinger G, Pavlova BG, Barrett PN.
    Vaccine; 2012 Jun 22; 30(30):4543-51. PubMed ID: 22475864
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination.
    Mulley WR, Visvanathan K, Hurt AC, Brown FG, Polkinghorne KR, Mastorakos T, Lewicki MC, Stuart RL, Tan SJ, Chean R, Kerr PG, Kanellis J.
    Kidney Int; 2012 Jul 22; 82(2):212-9. PubMed ID: 22495292
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.
    Ambati A, Einarsdottir S, Magalhaes I, Poiret T, Bodenstein R, LeBlanc K, Brune M, Maeurer M, Ljungman P.
    Transpl Infect Dis; 2015 Jun 22; 17(3):371-9. PubMed ID: 25817044
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of the trivalent influenza vaccination in Thai patients with hemodialysis or kidney transplant compared with healthy volunteers.
    Krairittichai U, Chittaganpitch M.
    J Med Assoc Thai; 2013 Mar 22; 96 Suppl 3():S1-7. PubMed ID: 23682516
    [Abstract] [Full Text] [Related]

  • 8. Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination.
    Choi YS, Baek YH, Kang W, Nam SJ, Lee J, You S, Chang DY, Youn JC, Choi YK, Shin EC.
    Clin Vaccine Immunol; 2011 Sep 22; 18(9):1519-23. PubMed ID: 21813667
    [Abstract] [Full Text] [Related]

  • 9. Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.
    Fairhead T, Hendren E, Tinckam K, Rose C, Sherlock CH, Shi L, Crowcroft NS, Gubbay JB, Landsberg D, Knoll G, Gill J, Kumar D.
    Transpl Infect Dis; 2012 Dec 22; 14(6):575-83. PubMed ID: 22999005
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of the antibody response to seasonal influenza vaccination among the elderly.
    Kositanont U, Assantachai P, Wasi C, Puthavathana P, Praditsuwan R.
    Viral Immunol; 2012 Dec 22; 25(6):471-6. PubMed ID: 23061793
    [Abstract] [Full Text] [Related]

  • 11. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
    Bai Y, Shi N, Lu Q, Yang L, Wang Z, Li L, Han H, Zheng D, Luo F, Zhang Z, Ai X.
    Hum Vaccin Immunother; 2015 Dec 22; 11(7):1648-53. PubMed ID: 26083828
    [Abstract] [Full Text] [Related]

  • 12. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT, Guo CY, Tsai MS, Cheng YY, Lin MT, Chen CH, Shen D, Wang JR, Sung JM.
    Vaccine; 2012 Jul 13; 30(33):5009-18. PubMed ID: 22658967
    [Abstract] [Full Text] [Related]

  • 13. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
    Strengell M, Ikonen N, Ziegler T, Kantele A, Anttila VJ, Julkunen I.
    Influenza Other Respir Viruses; 2013 May 13; 7(3):431-8. PubMed ID: 22913369
    [Abstract] [Full Text] [Related]

  • 14. Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.
    Herrera MT, Gonzalez Y, Juárez E, Hernández-Sánchez F, Carranza C, Sarabia C, Guzman-Beltran S, Manjarrez ME, Muñoz-Torrico M, Garcia-Garcia L, Sada E, Torres M.
    BMC Infect Dis; 2013 Nov 15; 13():544. PubMed ID: 24238117
    [Abstract] [Full Text] [Related]

  • 15. Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial.
    Le Corre N, Thibault F, Pouteil Noble C, Meiffrédy V, Daoud S, Cahen R, Charreau I, Bottigioli D, Dollinger C, Aboulker JP, Autran B, Morelon E, Barrou B.
    Vaccine; 2012 Dec 14; 30(52):7522-8. PubMed ID: 23103195
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study.
    Vinnemeier CD, Fischer-Herr J, Meyer S, Liebig K, Theeß W, Burchard GD, Cramer JP.
    Hum Vaccin Immunother; 2014 Dec 14; 10(2):441-8. PubMed ID: 24240428
    [Abstract] [Full Text] [Related]

  • 17. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
    Narang V, Lu Y, Tan C, Camous XFN, Nyunt SZ, Carre C, Mok EWH, Wong G, Maurer-Stroh S, Abel B, Burdin N, Poidinger M, Tambyah PA, Bosco N, Visan L, Ng TP, Larbi A.
    Front Immunol; 2018 Dec 14; 9():2465. PubMed ID: 30405641
    [Abstract] [Full Text] [Related]

  • 18. Seasonal maintenance of influenza vaccine-induced antibody response in kidney transplant recipients.
    Birdwell KA, Ikizler MR, Wang L, Byrne DW, Sannella EC, Wright PF, Ikizler TA.
    Am J Nephrol; 2012 Dec 14; 36(3):201-7. PubMed ID: 22906930
    [Abstract] [Full Text] [Related]

  • 19. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
    McVernon J, Laurie K, Barr I, Kelso A, Skeljo M, Nolan T.
    Influenza Other Respir Viruses; 2011 Jan 14; 5(1):7-11. PubMed ID: 21138535
    [Abstract] [Full Text] [Related]

  • 20. Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients.
    Brakemeier S, Schweiger B, Lachmann N, Glander P, Schönemann C, Diekmann F, Neumayer HH, Budde K.
    Nephrol Dial Transplant; 2012 Jan 14; 27(1):423-8. PubMed ID: 21613386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.